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11. Introduction
The trimethylbenzenes (TMBs) occur naturally in crude and shale oil. Due to their
presence in petroleum high volume chemicals such as motor fuels and solvent
mixtures the trimethylbenzenes are widely spread. Their exposure potential is
therefore high and they occur in ambient air and in occupational settings and may
pose a problem to human health and/or to the environment. The molecular
formula of the TMBs is the same for several other substances (e.g. methyl
ethylbenzene, propylbenzene, cumene) collectively referred to as C9 aromatics.
The TMBs also belong to the alkylbenzenes, such as toluene, ethylbenzene and
the xylenes. Due to the relatively high volatility of substances like the TMBs, the
main route of exposure is via inhalation. In general, the alkylbenzenes are known
to be narcotics and irritants to skin and mucous membranes (5).
Environmental concern has also been given the alkylbenzenes due to their
photochemical reactivity. The TMBs thereby contribute substantially to the
increase of photochemical oxidants, mainly ground-level ozone.
Data on the uptake and disposition of a chemical is important in the process of
risk assessment. Although the TMBs are frequently in use, such quantitative
human data was sparse when this work was initiated.
An exposure chamber for humans is at our disposal in our laboratory. It is
thereby possible to perform well defined and controlled experimental inhalation
exposures, a prerequisite for quantitative studies on uptake and disposition. The
chamber is 20 m3 and the subjects may be exposed at rest or exercise. Exposure
levels used in our studies do not exceed the present occupational exposure limits.
1.1 Toxicokinetics and biological monitoring
The toxicity of a chemical can be described by its kinetic and dynamic
characteristics. Toxicokinetics is the mathematical description of the time course
of a chemical in the body. It comprises of different processes: the uptake,
distribution, metabolism (biotransformation) and excretion. Thus, toxicokinetics
provides information on the concentration of the chemical at the site of action.
The underlying assumption is that a potential risk to health is related to that target
tissue concentration or internal dose of the chemical or its metabolites. The
toxicodynamic features describe the mechanism of action at the target site.
Traditionally, in the occupational setting air levels have been used to estimate the
internal dose. One advantage of ambient air monitoring is that it gives a measure
of the occupational exposure alone. For a variety of reasons, however, ambient
monitoring may not reflect the internal dose. In the case of varying exposure
levels the sampling period may be too short. Further, an increased physical
activity will increase pulmonary ventilation and cardiac output thereby affecting
uptake, distribution and elimination. Individual characteristics, such as
constitution or metabolic capacity will also affect target tissue dose and hence, the
2risk for adverse human health effects. Also, other routes of exposure, e.g. dermal
uptake may contribute to the total internal dose.
Instead of using air levels, internal dose may be estimated from biological
exposure indices, e.g. the concentration of the parent compound or its metabolites
in blood, urine or exhaled air. Biological exposure indices will reflect all, not only
occupational, exposure. Biological sampling is also the only possible way of
evaluating the performance of personal protective equipment.
Most experimental studies on kinetics or toxicity are performed on single
chemicals, while occupational and environmental exposures often are to mixtures
of substances. Toxicokinetic (and toxicodynamic) interactions between chemicals
or components in mixtures may occur which in turn affect risk assessment.
Further, the proper use of biological exposure indices from multiple exposure
situations requires an awareness of such interactions.
Toxicokinetic modelling may be used to describe, predict or explain data and is
largely based on the visualisation of the body as consisting of one or several
compartments. Two commonly used types of toxicokinetic modelling are a) data
based and b) physiologically based. The classical descriptive, data based
compartmental analysis is based on mathematical regression and curve fitting.
The number and characteristics of the compartments depend on the equation
chosen to describe the data. By the second approach, physiologically based
pharmaco- or toxicokinetic modelling, the organism is described by
physiologically realistic compartments (tissue groups) of known volumes with
connecting blood flows. Tissues are lumped together into compartments
according to blood flow and fat content. Apart from physiological characteristics
such as organ volumes and blood flows, also chemical specific data such as
partition coefficients and reaction rate constants are included. Partition
coefficients determine how a substance will divide between different media, e.g.
blood and air, and are decisive for the toxicokinetic behaviour of the chemical.
Mathematically, the physiological model is defined by a set of mass balance
equations or differentials. Such models have a higher predictive power than the
data based mathematical models and allow for extrapolating, e.g. between dose
levels and species. Thus, the influence on the kinetics from co-exposure to other
xenobiotics, physical exercise and individual characteristics may be studied
making physiological modelling a valuable tool in risk assessment and in the
development of biological markers.
31.2 Aims of the study
The main purpose of this thesis was to study the toxicokinetics of the
trimethylbenzenes in humans and to obtain quantitative data in order to address
the issue of biological monitoring of exposure to TMB-containing products. More
specifically the aims were to:
a. study the inhalation toxicokinetics, i.e. respiratory uptake, distribution,
metabolism and excretion of 1,2,3-, 1,2,4- and 1,3,5-TMB, respectively (Paper
II).
b. compare the inhalation toxicokientics of the TMBs, and 1,2,4-TMB in
particular, after exposure to the substances alone with the kinetics after
exposure to a commonly used TMB-containing product, i.e. white spirit (Paper
V).
c. study the urinary excretion of specific metabolites and their suitability as
biological markers of exposure (Papers III and IV).
d. develop a physiologically based toxicokinetic model for inhalation exposure of
1,2,4-TMB to expand to different exposure scenarios and address the issue of
biological exposure monitoring (Papers I and VI).
e. screen for acute symptoms of irritation and CNS-effects (Papers II and V).
42. Review of the literature on the
trimethylbenzenes
2.1 Chemical structure and nomenclature
TMBs are mono-aromatic hydrocarbons with the molecular formula C
9
H
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. Like
the xylenes the methyl groups can be positioned in different ways giving three
isomeric forms of TMBs. These are 1,2,3-TMB, 1,2,4-TMB and 1,3,5-TMB
(Figure 1). Common names and CAS-numbers are given in Table 1.
1,2,3-TMB
CH3
CH3
CH3
1,2,4-TMB
CH3
CH3
CH3
 
1,3,5-TMB
CH3
CH3
CH3
Figure 1. Structural formulas of the TMBs.
2.2 Physical properties
The TMBs are clear, colourless liquids with aromatic oily odours which for the
1,3,5-isomer has been described as sweet or peculiar. An odour threshold of 0.55
ppm is reported for that isomer. The TMBs  are miscible with organic solvents
such as benzene, ethanol, and ethyl ether but are practically insoluble in water.
The molecular weight is 120.2. For conversion between mg/m3 and ppm (ml/m3),
Table 1. Nomenclature of the TMBs
Rational name CAS-No. Synonyms
1,2,3-TMB 526-73-8 Hemimellitene
1,2,4-TMB 95-63-6 Pseudocumene, asymmetrical TMB, 
pseudocumol, psi-cumene
1,3,5-TMB 108-67-8 Mesitylene, symmetrical TMB
Mixed isomers 25551-13-7
5Table 2. Physical properties of the TMBs
Property 1,2,3-TMB 1,2,4-TMB 1,3,5-TMB
Boiling point (°C) 176 169 165
Melting point (°C) -25.4 -43.8 -44.7
Density (g/ml, 20°C) 0.8987 0.8761 0.8637
Vapour pressure (kPa) 0.233 (35°C) 45.5 (140C) 0.248 (20°C)
Satur vapour conc (ppm) 1320 (17°C) 6500 (38°C) 6550 (35°C)
Flash point (°C) 51 44 50
1 mg/m3 = 0.20 ppm and 1 ppm = 4.92 mg/m3 at 25 °C. Some other physical
properties are listed in Table 2 (20, 50-52, 58). Estimated Log octanol-water
partition coefficient (Kow) for the TMBs is 3.63 (62). The corresponding
experimental value for 1,3,5-TMB is 3.42 (33).
2.3 Occurrence
1,3,5-TMB is used as an intermediate in the dye and plastics industries and as a
synthetic intermediate in the production of an antioxidant used as stabiliser in
polymers like polyethylene, polypropylene, polyamides, adhesives, rubbers and
wax and printing inks. 1,3,5-TMB is also used in paint and varnish formulations,
in paint thinners, and in pesticide formulations (50).
Oxidation of 1,2,4-TMB yields trimellitic acid which may be converted to its
anhydride. Trimellitic anhydride is used as an intermediate in the manufacture of
alkyd resins, plasticizers and unsaturated polyesters, adhesives, dyes and printing
inks (1). 1,2,4-TMB is also used as solvent for coatings, cleaning fluids, pesticide
formulations and inks. It occurs in scintillation counting fluids, dye carriers and
ultraviolet stabilisers in plastics and polymer resins (51). It is an insect attractant.
The US production of 1,2,4-TMB was 36 000 ton in 1989 (41). 1,2,3-TMB is
used in the manufacturing of perfumes (52).
Finally, all TMB isomers occur in motor fuels and in solvent mixtures. The
dominating isomer, 1,2,4-TMB, is registered in 145 products in Sweden covering
solvent mixtures and a few scintillation counting fluids. The figure is an
underestimation since the occurrence of TMBs in complex products may not be
explicitly reported (75). Neat TMBs are not used at all, except for laboratory uses.
The largest quantities are used in petrol (containing approximately 2% TMBs)
and 78 000 tons of TMBs were produced for that purpose in Sweden in 1992 (41).
As a consequence of the occurrence in vehicle fuel, TMBs have been detected in
urban air in trace quantities (55, 81-83). Main end uses of solvent mixtures are,
e.g. in the surface coating, adhesives and the rubber industry. Common products
containing TMBs are for instance with trade names: Shellsol, Solvesso and White
6Spirits. The fraction of TMBs in these products varies from a few percent up to
approximately 50%.
2.4 Toxicokinetics
Absorption occurs predominately and readily via inhalation, but also from the
gastrointestinal tract (4). Limited data suggests that uptake through the skin is
slow (31). The TMBs passes the placenta (15, 87). The in vitro blood/air partition
coefficient of 1,3,5-TMB has been determined to be 44 (39) and that of 1,2,4-
TMB to be 54 and 87 (13, 86). The relative respiratory uptake in man exposed for
2 h at rest to 1,2,4-TMB in white spirit has been estimated to be 62% (94). The
uptake of 1,3,5-TMB during an 8-h inhalation at rest stabilised at 67% after 2 h
(49).
No estimations of the human distribution of TMBs had been performed when
this work was initiated. In rats exposed to 100 ppm of 1,2,4-TMB, the by far
highest concentrations were found in fat. Of organs measured, the kidney (91), or
kidney and liver (36), had the highest levels. In humans exposed to 1,3,5-TMB
vapour a triphasic elimination profile with a slow terminal phase was shown (49)
indicating an affinity for adipose tissue.
Generally, alkylbenzenes are hydroxylated by the cytochrome P-450 system
(57). It has not been shown what isozyme is responsible for the initial oxidation of
the TMBs. The corresponding biotransformation of toluene and m-xylene,
however is catalysed by the CYP2E1 isozyme (59, 67).
Oxidation can occur at the aromatic nucleus or at the aliphatic side chain. Initial
aromatic hydroxylation yields a trimethylphenol. Side chain oxidation gives
initially a dimethylbenzyl alcohol. The alcohols and phenols may be sulphated or
glucuronidated. Conjugation with glutathione also occurs yielding finally a
mercapturic acid derivative. Instead of being conjugated, dimethylbenzyl alcohol
may be further oxidised to dimethylbenzoic acid (DMBA). The DMBAs in turn
may be excreted directly in the urine or conjugate with glucuronic acid or glycine.
The glycine conjugate is called dimethylhippuric acid (DMHA). Indications of
DMHAs being further conjugated have been reported (36). The metabolic
pathways of the TMBs are given in Figure 2 exemplified with 1,2,4-TMB. Due to
the asymmetry of the 1,2,4-TMB molecule the number of potential metabolites is
large.
In the male rat, most of the above mentioned metabolites of 1,2,4-TMB have
been detected after oral administration. The most predominant metabolites are
conjugated dimethylbenzyl alcohols (26% of administered dose) and DMHA
(approximately 40%) (36, 64). Some controversy exists about the importance of
aromatic hydroxylation. Reported values range from 0.05% to 12% of equivalent
oral doses (4, 36). Glucuronides and sulphates have been estimated to account for
7 and 13% respectively, of orally administered 1,2,4-TMB (64).
In the male Wistar rat, 3,5-DMHA is the main metabolite (42% or 78%) (63,
64) of 1,3,5-TMB while the urinary excretion of 2,4,6-trimethylphenol is very low
(0.4-0.5%) (4, 63). Urinary metabolites also include a mercapturic acid derivative
7COOH
Dimethylhippuric
acid
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Dimethylbenzyl
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Figure 2. Suggested metabolism and elimination of the TMBs, exemplified by 1,2,4-
TMB.
(4%) (88). In male rabbits, the urinary excretion of 3,5-DMHA (68.5%), free 3,5-
DMBA (9%) but also a diacid, 5-methylisophtalic acid (1.2%) is reported (53). A
tendency, although not significant, towards increased 1,3,5-TMB blood levels was
seen in rats after intraperitoneal injection of ethanol (20 mmole/kg) before
exposure to 110 and 580 ppm of 1,3,5-TMB (76). Co-exposure with benzene has
been found to increase the yield of DMHA from 42 to 59% (63).
In humans exposed to 1,3,5-TMB vapour the half-times of 1,3,5-TMB in blood
were 1.6 min, 0.72 h and 46 h, respectively. As much as 73% of the absorbed
dose was recovered as 3,5-DMBA or 3,5-DMHA. Half-times of free and
conjugated DMBAs were 6.5 h and 34.7 h (49). A urine/air partition coefficient of
18.5 for 1,3,5-TMB has been reported (39).
Published data on the kinetics of 1,2,3-TMB were very few when this work was
initiated. In rats, glycine conjugates, glucuronides and sulphates were excreted in
roughly equal proportions, each corresponding to 17-20% of an oral dose (1.2
g/kg) (64). Only 0.3% of an orally administered dose was excreted as urinary
phenols (63).
8The influence from sterical factors might be seen in the metabolite pattern of
the different TMB isomers. Oxidation at the aromatic nucleus seems relatively
insensitive to sterical factors considering that the three possible phenols arising
from oxidation of 1,2,4-TMB are formed at approximately equal proportions.
Some sterical influence on initial side chain oxidation seems to occur but even
more so on the successive oxidation of the dimethylbenzyl alcohols. Thus, the
3,4-dimethylbenzyl alcohol is to a greater extent oxidised to a DMBA than are the
other two alcohols. Also conjugation with glycine seems to be influenced by
sterical factors (11, 36). Two enzymes are involved in glycine conjugation,
namely acyl CoA synthetase and acyl CoA-glycine N-acyl transferase. The
Michaelis constant (Km) for the formation of DMHA from 3,4-DMBA and 3,5-
DMBA has been estimated to be 420 and 490 m M, respectively (63). Km-values of
the remaining DMBAs, having methyl groups ortho to the carboxyl moiety, could
not be determined in the referred study due to a low yield of the product. The
different DMHA-isomers originating from the respective TMB are given in Table
3. The position numbers are valid also for the dimethylbenzyl alcohols and the
dimethylbenzoic acids.
All TMBs induce rat liver cytochrome P-450 (74, 87). In the lungs, the
response is a decreased concentration of pulmonary cytochrome P-450. This
finding may be explained by aldehyde intermediates reaching toxic levels due to a
deficiency of aldehyde dehydrogenase in the lung. In the liver the aldehydes are
rapidly converted to acids (74). One study indicates that 1,3,5-TMB stimulates the
glucuronidation route of elimination (89).
2.5 Toxicity
2.5.1 General toxicity
Acute oral toxicity of 1,2,4-TMB is low based on two independently
established LD50 values of 3400 and 6000 mg/kg (20). Chronic inhalation of a
high flash aromatic naphtha containing 45% TMB (with 1,2,4-TMB being the
dominating isomer) at exposure levels up to 165 ppm total TMBs was considered
without systemic toxicity on rats (12).
Table 3. Nomenclature of DMHA-isomers
Parent TMB DMHA-isomer
1,2,3-TMB 2,3-DMHA
2,6-DMHA
1,2,4-TMB 2,4-DMHA
2,5-DMHA
3,4-DMHA
1,3,5-TMB 3,5-DMHA
9Inhalation exposure (8 h/d, 14 d) of 1800-2000 ppm 1,2,4-TMB caused no injury
(9). Subacute (6 h/d, 12 d) inhalation of 2000 ppm 1,2,4-TMB caused respiratory
difficulties in rats (28).
The minimal concentration of 1,3,5-TMB vapour causing a loss of reflexes
during a 2-h exposure was 7100-9100 ppm. A loss in righting response occurred
at inhalation levels of 5100-7100 ppm (56) (the exposure levels reported seem to
exceed the approximate saturated vapour concentrations). Single exposure to 560
ppm for 24 h did not cause any adverse effect in rats whereas animals exposed to
2240 ppm suffered from respiratory failure and depression of the CNS (9). In rats,
6 h inhalation of 300, 600 and 1200 ppm 1,3,5-TMB caused an increase in
neutrophiles at the highest level but no blood count changes (90).
No oral single dose data on 1,2,3-TMB has been found.
In the rat, all TMBs caused disturbed rotarod performance and decreased pain
sensitivity performance in a concentration dependent manner after acute 4-h
exposures to 250-2000 ppm. Concentration dependent disturbances in the
performance of the same tests were seen also at subchronic inhalation of 1,2,3-
and 1,2,4-TMB at levels up to 250 ppm. Decreased pain-sensitivity appeared even
at the 25 ppm exposure to 1,2,3-TMB. Generally, the effects after both acute and
subchronic exposure of 1,2,3-TMB were more pronounced than those of the other
TMBs. In mice, 1,2,4-TMB caused a concentration dependent decrease in
respiratory rate and the concentration (95% CI) depressing the value to 50% was
578 (311-793) ppm (47, 48). In male Wistar rats, a 4-week inhalation exposure to
1,2,4-TMB indicated behavioural changes at 100 ppm (increased motor activity, a
changed hot plate behaviour and an impaired passive avoidance). Also effects of
exposure to 1,2,3-TMB were briefly mentioned in this paper. Passive avoidance
was impaired already at 25 ppm (32).
2.5.2 Irritation
Liquid 1,3,5-TMB applied for 4 h to rabbit skin caused severe irritation (42)
whereas liquid 1,2,4-TMB had a slight skin and eye irritation potential in a study
on rabbits (20). In a briefly reported study, 2000 ppm of 1,2,4-TMB vapour
caused eye and nose irritation whereas irritation at 1000 ppm was reported as
initial and slight (28). No data on the irritation potential of 1,2,3-TMB was found.
2.5.3 Reproductive toxicity
In a 3-generation inhalation reproduction study in rats on C-9 aromatics
containing at least 50% TMBs, fertility was not affected but offspring survival
and growth was affected at 272 and 816 ppm total TMBs. No effects on the
offspring were seen at the lowest dose level of approximately 55 ppm TMBs.
In mice, an aromatic mixture containing 55 ppm TMBs had no developmental
effects. At 825 ppm TMBs maternal toxicity was severe and mean fetal
weight was largely reduced and developmental defects were seen (20).
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2.5.4 Genotoxicity and carcinogenicity
Limited data indicate that the TMBs are not genotoxic (80). No data on
carcinogenicity have been found.
2.5.5 Health effects in humans
Little information is available on the human toxicity of the TMBs. As
occupational exposure generally is to mixtures, the possibility of ascribing
potential effects to a single substance is limited.
ÒFleet-X-DV-99Ó is a paint thinner containing 50% of 1,2,4- and 30% of 1,3,5-
TMB, and possibly small amounts of the 1,2,3-TMB isomer as well as
methylethylbenzene. Workers occupationally exposed to this product at an
atmospheric concentration of 10-60 ppm experienced nervousness, tension,
anxiety, asthmatic bronchitis, CNS-depression and respiratory irritation. In
addition, a tendency towards a deviation from normal coagulation was shown (8).
This may, however, be due to the presence of benzene as a contaminant in the
solvent mixture (31). One person exposed to 1,2,4-TMB used as a solvent in
liquid scintillation counting solutions experienced CNS-symptoms, hepatopathy,
chronic gastritis and conjunctivitis (45). Concentration in serum 2 h after
exposure was reported to be 0.20 ppm corresponding to 0.008 µM.
A recent study on male and female workers occupationally exposed to the
solvent mixture Farbasol, consisting of more than 30% of 1,2,4-TMB, and to 95%
of alkyl benzenes, within or below 1.5 of MAK-values (no further information
specified), indicated subclinical effects on the CNS. Reported symptoms include
headache, vertigo, concentration difficulties, sleep disorders, emotional irritability
and mood swings. Some of the symptoms were related to the cumulative dose
and/or duration of exposure (40).
2.6 Occupational exposure and biological monitoring
High boiling points and relatively high flash points make the TMBs attractive for
use in the occupational setting. A major part of occupational exposure to the
TMBs, however, originates from exposure to complex mixtures. Exposure occurs
in, e.g. the painting, printing and transport industry. TMBs has also occurred in
solvent mixtures used for graffiti removal (3). Measurements in the United
Kingdom in different industries revealed that virtually all TMB-exposures were
below 25 ppm (20).
Several authors have suggested that the DMHAs or DMBAs might be suitable
biological markers of exposure to TMBs or TMB-containing products (6, 26, 38,
71). Occupational air levels of the TMBs in the referred studies were below 40
ppm. A positive approximately linear correlation was found between creatinine-
corrected concentrations of 3,4-DMHA and the time-weighted average (TWA) of
1,2,4-TMB exposure (26, 38).
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2.7 Occupational exposure limits
The present Swedish occupational exposure limit (OEL) is 25 ppm or 120 mg/m3.
The short-time value is 170 mg/m3 (34). A short-time value is a recommended
time weighted average value for exposition during a reference period of 15
minutes. The OEL for white spirit is 300 mg/m3 corresponding to approximately
50 ppm. Short-time values for white spirit are twice the OELs, 600 mg/m3 (100
ppm).
Several countries have an 8-h threshold limit value (TLV)-TWA of 25 ppm,
including USA (ACGIH) (37), United Kingdom, Australia, Denmark, Finland and
Japan (20). In Germany, no MAK-value for the TMBs has been established due to
inadequate available data (25).
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3. Methods
In this section, a short overview of the methods used is given. More details are
given in the original papers. All human exposures were performed after informed
consent and according to the Helsinki declaration and were approved by the
regional ethical committee at the Karolinska Institute, Solna, Sweden.
3.1 Determination of liquid/air partition coefficients in vitro  (Paper 1)
By definition, the partition coefficient (l) of a chemical is the ratio of its
concentration (C) in two phases at equilibrium.
l liquid/air = Cliquid / Cair
The kinetics of volatile substances depends largely on the partitioning between
blood and air and between blood and other tissues. Liquid/air partition
coefficients were determined in vitro by the closed vial equilibration method (79).
Liquids used were physiological saline, pooled fresh human blood and olive oil.
In brief, different amounts of vaporised TMBs were added to pre-sealed vials
containing a known volume of the liquid. After equilibration at 37°C the head
space was analysed by gas chromatography. The same amount of TMBs was
added to reference vials containing glass beads instead of liquid. Since no
partitioning would occur in the reference vials and all volumes were known, the
partition coefficients could easily be calculated.
3.2 Chamber exposures (Papers II, IV and V)
Ten male Caucasian volunteers were exposed to vapour of the TMBs in a
chamber. The subjects were healthy as judged by a general medical examination
including analysis of standard blood chemistry. They were not occupationally
exposed to solvents and were instructed to avoid intake of drugs and alcoholic
beverages and contact with organic solvents at least 2 days before exposure.
Nominal exposure levels were 25 ppm (120 mg/m3) of each TMB isomer and,
in addition, 2 ppm (11 mg/m3) of 1,2,4-TMB. The 25 ppm-level corresponds to
the present OEL in Sweden. The 2 ppm level was chosen to match exactly the
level of 1,2,4-TMB obtained after complete vaporisation of white spirit to reach
300 mg/m3. At a later occasion the same men, except one that could not
participate, were exposed nominally to 300 mg/m3 of white spirit (paper V). The
exposure to white spirit was conducted approximately one year after the exposure
to TMBs. The emphasis was on 1,2,4-TMB as it is the dominating TMB-isomer in
white spirit.  Exposures were conducted at a physical workload of 50 W
performed on ergometer bicycles to imitate the conditions in light industry work
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(60). The concentration of chamber TMB or white spirit levels were monitored by
infrared spectrophotometry. The concentration of TMB in chamber air varied less
than 4% during a 2 h exposure to 25 ppm and less than 3% between days,
expressed as coefficient of variation. Arterialised blood, urine and exhaled air was
sampled during and after exposure and the concentration of parent TMB was
analysed by head space (blood, urine) or conventional (exhaled air) gas
chromatography.
Arterialisation was achieved by the Òheated-hand techniqueÓ (68). Heating of
the hand was performed by dipping it into hot water before sampling. During
exposure, blood was sampled outside the chamber in a transparent glove box
flushed with clean air. This procedure was undertaken to minimise the risk of
contaminating the samples with solvent outside the chamber. Collected blood was
immediately transferred to gas-tight head space vials that were capped with
Teflon-coated membranes.
All urine was collected in glass bottles from the onset of exposure and until the
following morning. TMB in urine was only determined in samples collected on
the day of exposure as they had to be analysed immediately due to the
unfavourable partition coefficient. A specimen of each urine sample was stored at
-18°C for subsequent analysis of DMHAs by high performance liquid
chromatography (HPLC) (Section 3.3). Further, the urinary excretion of
unconjugated DMBAs was estimated by analysis of all the urine specimens from
one individual, and in addition, by analysis of all urine specimens from all
subjects and all exposure conditions but only at 2 h post exposure.
Exhaled air was sampled at selected intervals in polyester laminated aluminium
foil bags. During sampling the subjects wore a nose clip to prevent nasal
breathing. Each sampling period was for three minutes. The volume of the expired
air was measured with a balanced spirometer. Pulmonary ventilation was
measured as the collected air volume (corrected to body temperature and pressure,
and saturated air) divided by the sampling time. Ventilation was determined at
exercise during exposures and in an upright sitting position post exposure.
Individual blood standards were prepared from blood collected before the
subjects went into the chamber. Urine standards were prepared for each individual
when voided volumes were adequate. Otherwise the voided volumes for the two
subjects that were exposed together were pooled.
All sampling in connection with white spirit exposures was as described above
except for exhaled air. Due to a long analysis time of white spirit it was
impossible to perform analysis of the expired air in connection with the exposure.
Instead, a portion of the samples was transferred to head space vials for
subsequent analysis by head space gas chromatography. Standards were prepared
by filling polyester laminated aluminium foil bags with a known volume of air
and known volumes of liquid white spirit. Standards were treated in exactly the
same way as the specimens.
Due to analytical difficulties 1,2,3-TMB in white spirit could only be
determined in exhaled air. The 1,3,5-TMB isomer could not be quantitatively
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Table 4. Partial composition of a particular batch of white spirit used in paper V
Substance  % (v/v) Substance  % (v/v)
n-hexane 0.5 xylenes 1.2
n-octane 0.9 1,2,4-TMB 3.4
n-nonane 8.1 1,3,5-TMB 2.3
n-decane 18.9 1,2,3-TMB 1.4
n-undecane 10.0
n-dodecane 1.4
analysed at all due to interfering peaks in the blanks but was detectable in exhaled
air and blood.
White spirit, mineral spirit, mineral turpentine, petroleum spirits and Stoddard
solvent are all synonyms for a mixture of alkanes, cycloalkanes and aromatic
compounds with 7-14 carbon atoms. The relative evaporation rate is 0.15
(butylacetate = 1). Exposure to white spirit is probably a major source of
occupational exposure to the TMBs in Sweden. In the present study a traditional
white spirit was used, with hydrocarbons predominantly with 7-12 carbon atoms,
a boiling point interval of 157-200°C and 16% aromatics (v/v). The flash point
was 43°C. Products of this kind have been shown to contain well over 200
different compounds (19). The proportion of some of the constituents in a
particular batch used in the white spirit exposures is given in Table 4, as
determined by gas chromatography.
3.3 Toxicokinetic calculations (Papers II and V)
Individual kinetic calculations were performed on data from all exposures. The
data analysis, however, was somewhat different in Paper II from that in Paper V.
In paper II, the post-exposure excretion of unmetabolised solvent in exhaled air
was estimated from the area under the respiratory excretion rate versus time curve
according to a biexponential expression. Further kinetic calculations were
performed by entering blood concentration versus time data into a four
compartment mamillary model with zero-order input into the central compartment
and first-order elimination by exhalation and metabolism from the central
compartment. Thus, other ways of elimination, e.g. renal clearance were
considered negligible. Skin uptake was assumed to be zero. Additional input data
were net uptake, time of exposure and the amount exhaled post-exposure. The
model accounted for the fraction of the absorbed amount cleared by exhalation
during and after exposure. For lipophilic substances like the TMBs, use of a
multicompartment model is expected as distribution processes are expected to be
slow compared with elimination. A four-compartment open model was used as we
wanted to depict the washout from lung alveoli, distribution to rapidly and slowly
perfused compartments and adipose tissue. In a mamillary model uptake and
elimination occur via the central compartment and transfer of chemical takes
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Figure 3. Four compartment mamillary model with uptake and elimination from the
central compartment. Dilution volumes (V) and rate constants (k) are depicted.
place between each peripheral compartment and the central one. All processes
were assumed to be first-order except for the constant inhalation which was
assumed to be zero-order. In fitting the model to the data, the ordinary least
squares method (OLS) was used for minimising the residual sum of squares. The
model is depicted in Figure 3.
The data from white spirit exposures was put into a two-compartment model.
As in the four-compartment model used for TMB-exposures all the processes
were first-order except for uptake which was zero-order. The model was
simultaneously fitted to the blood and exhalation rate data. The criterion for best
fit was the iteratively reweighted least squares (IRLS). The model is depicted in
Figure 4.
Figure 4. Two compartment model with dilution volumes (V) and rate constants (k).
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3.4 Chemical analysis of metabolites in urine (Papers III, IV and V)
A method for the analysis of DMHAs in urine was developed. The method
included a clean-up procedure before analysis by HPLC. In brief, 2.5 ml of
acidified urine was extracted three times with 5 ml dichloromethane. After
evaporation, the residue was dissolved in the mobile phase. Mobile phase A
(1.25% acetonitrile and 0.3% acetic acid in water) was used from the beginning of
the chromatographic analysis and up to 59.5 min. Eluent B (5% acetonitrile and
0.3% acetic acid in water) was used until termination of the analysis at
approximately 90 min. DMHAs were detected at 225 nm. By this method all six
DMHAs were separated. Detection limits were less than 1 mg/ml for the main
DMHA formed from each TMB isomer, i.e. for 3,4-DMHA (from 1,2,4-TMB),
for 2,3-DMHA (1,2,3-TMB), for 3,5-DMHA (1,3,5-TMB) and in addition for 2,4-
DMHA (1,2,4-TMB).
Unconjugated DMBAs were analysed essentially according to Pfffli and
Savolainen (71) but excluding the hydrolysation step. In addition, pKa-values for
DMHAs and DMBAs were determined by potentiometric titration.
3.5 Rating of acute symptoms (Papers II and V)
Irritation and CNS-effects were studied by ratings on a 100 mm visual analogue
scale. The questions included symptoms such as discomfort in eyes, nose, throat
or airways, headache, fatigue, nausea, dizziness, intoxication, difficulty in
breathing. A question on smell was included to check the sensitivity of the scale
to determine feelings of discomfort. The scale was verbally graded from Ònot at
allÓ to Òalmost unbearableÓ (Figure 5).
The scale was originally developed for assessing annoyance from noise in the
working environment (46). The questionnaire had previously been used in
inhalation studies on mono-terpenes (21).
hardly
at all
somewhat rather quite very
almost
unbearable
not
at all
Figure 5. Visual analogue scale for the rating of symptoms in connection with exposure
to TMBs and white spirit.
3.6 Physiologically based modelling of 1,2,4-TMB inhalation kinetics (Paper
VI)
A physiological model describing inhalation kinetics of 1,2,4-TMB was
developed. The model was used to investigate how different factors influence
potential biological markers of TMB exposure. Experimental data from the 2 and
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25 ppm exposure to 1,2,4-TMB alone was used in the development. It was
assumed that all influent chemical is equilibrated within the tissue or
compartment, i.e. the transfer rate is limited by blood flow and not diffusion
across membranes. Hence, the model is said to be flow- or perfusion-limited.
Tissue/blood partition coefficients were needed for the modelling and were
calculated by two approaches. Firstly, empirically derived equations giving
tissue/blood partition coefficients from the fat/blood partition coefficient were
used (23). Fat/blood partition coefficients for the TMBs were calculated from the
previously determined liquid/air partition coefficients (Paper I) assuming that fat
tissue consists of 70% fat and 30% water. Secondly, tissue/blood partition
coefficients for TMB were estimated from tissue composition data (70). The
lowest tissue/blood values obtained by the second approach agreed well with
those obtained by the empirical relationships. The actual values used in the model
was an average of the predictions obtained by the two methods except for the
rapidly perfused tissue/blood partition coefficient that could only be estimated by
the empirical equation. For convenience, this coefficient was set equal to that
obtained for brain (23).
The number of compartments in the model will depend on the chemical specific
characteristics and physiological considerations. For inhalation exposure of
volatile, lipophilic substances such as the TMBs, a lung and fat compartment is
required. The final model was defined by six physiological compartments
regarding the transfer of 1,2,4-TMB and, in addition, one compartment describing
the formation and excretion of 3,4-DMHA. A special feature of the model was the
division of hepatic metabolism into two different routes, one linear (formation of
3,4-DMHA) and one of the Michaelis-Menten type. Further, muscles were
divided into two separate compartments of equal volumes corresponding to
working and resting muscles. This was done to account for the change in blood
flow occurring during exercise (here performed on a bicycle ergometer during
exposure) (44). It was assumed that the whole increase in blood flow during
exposure was attributed to the compartment of working muscles. Post-exposure
work load was set to 25 W corresponding to normal indoor activities (95). Work
load during the night was set to 0 W. Rapidly perfused tissues (brain and kidney)
constituted one compartment. The formation of 3,4-DMHA was calculated as the
intrinsic clearance for 3,4-DMHA-formation times the 1,2,4-TMB hepatic
concentration. The excretion of the metabolite in urine was calculated as an
elimination rate constant multiplied by the amount formed.
Individual compartmental volumes and blood flows were scaled according to
lean body volume. Blood flows were also adjusted according to work load (17).
The previously obtained experimental data was used to obtain estimates on the
following parameters: alveolar ventilation at rest, the metabolic parameters and
the rate constant for excretion of 3,4-DMHA. The metabolic parameters were Vmax
(maximum metabolic rate) and Km (Michaelis-Menten constant) for the route
described by Michaelis-Menten-kinetics, and intrinsic clearance for the formation
of 3,4-DMHA. Thus, individual simulated blood concentrations, exhalation rates
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lungs and arterial blood
Qco
liver
resting muscles
working muscles
Cair
Qalv Qalv
Calv
rapidly perfused tissues
Qrap
Qco
Qf
Qw
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Qh
CartCven
adipose tissues
other
metabolites
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urine
3,4-DMHA
Vmax/Km
urine
Figure 6. Physiological model for inhaled 1,2,4-TMB.
Qalv = alveolar ventilation; Cair = TMB-concentration in inhaled air; Calv =
concentration in alveolar air; Qco = cardiac output; Cart = concentration in arterial blood;
Cven  = concentration in venous blood; CLi = intrinsic hepatic clearance; Qi = blood
flow to compartment i; Subscripts for compartment i are as follows; rap = rapidly
perfused tissues; f = adipose tissues; w = working muscles; r = resting muscles; h = liver.
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and urinary excretion rates of 3,4-DMHA were simultaneously fitted to the
experimentally determined values from the two exposure conditions by adjusting
these five parameters. The IRLS method was used for minimising the residual
sum of squares. The parameter values obtained for one of the subjects were used
for subsequent simulations of 1,2,4-TMB kinetics at several exposure conditions.
The model was used to expand from the constant 2 h exposure used in the
experiments to constant 8 h exposure at different work loads and air levels as well
as a full working week. The influence from these various conditions on different
biological markers of 1,2,4-TMB exposure was investigated. Further, the
influence of interindividual variability on biomarker levels was assessed.
Moreover, the influence from fluctuating exposure on the level of potential
biomarkers was studied by 500 Monte Carlo simulations of randomly generated
8-h exposures with a TWA of 25 ppm. Two exposure scenarios were generated.
The two scenarios corresponded to a) continuous emissions at a high rate of air
exchange and b) intermittent emissions at a minimal rate of air exchange.
The model was written in the software packages WinNonlin 1.1 (for fitting the
model to the data) and Simnon 2.0 (for simulations) and is illustrated in Figure 6.
3.7 Statistical analysis
Unless stated otherwise, results are presented as arithmetic means (95%
confidence intervals). StudentÕs paired t-test or repeated measures analysis of
variance (ANOVA) was used for comparisons of means regarding kinetic
parameters. Subjective ratings were evaluated by repeated measures ANOVA.
The level of statistical significance was set to 0.05.
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4. Results
4.1 Liquid/air partition coefficients (Paper I)
Blood/air and olive oil/air partition coefficients were high whereas the affinity for
water was limited (Table 5). The large values on the blood/air and olive/oil
partition coefficients indicate a high respiratory uptake and a high affinity for
adipose tissue, respectively. The results are consistent with previous findings with
other aromatic hydrocarbons.
From the liquid/air partition coefficients tissue/blood partition coefficients may
be calculated. Thus, tissue/blood partition coefficients for the TMBs were
predicted by empirical linear correlation equations describing the relation between
tissue/blood and adipose tissue/blood partition coefficients. Adipose tissue/blood
partition coefficients for the TMBs were calculated based on the fraction of fat
(70%) and water (30%) in the tissue (Table 6) (23).
Table 5. Partition coefficients of trimethylbenzenes in blood, watera and oil at 37°C.
Mean values and 95% confidence intervals are given.
Substance Blood/air Water/air Oil/air 
n = 39 n = 42 n = 25
1,2,3-TMB 66.5 (63.7-69.3) 2.73 (2.54-2.92) 10 900 (10 500-11 300)
1,2,4-TMB 59.1 (56.9-61.3) 1.61 (1.47-1.75) 10 200 (9 900-10 400)
1,3,5-TMB 43.0 (40.8-45.2) 1.23 (1.11-1.35)   9 880 (9 620-10 140)
a strictly physiological saline
4.2 Inhalation toxicokinetics of the TMBs (Paper II, IV, V)
During exposure to 25 ppm TMBs for two hours the relative respiratory uptake
amounted to 56-64% for the three isomers (measured net uptake plus the amount
cleared by exhalation during exposure). The levels of the TMBs in arterial blood
rose rapidly without reaching a plateau during the 2 h exposure. At the end of
exposure, blood levels were on average 6-7 mM. The four half-times obtained
were 1-2 min, 21-27 min, 4-5 h and 78-120 h. Thus, the terminal elimination
phase of the TMBs is slow. Apparent volumes of distribution were large, 30-39
l/kg or 2300-3000 l. These findings are consistent with a substantial accumulation
in adipose tissue. Kinetic parameters estimated from the 25 ppm exposures are
summarised in Table 7. All results are based on a respiratory uptake calculated as
the sum of the measured net uptake and the estimated amount exhaled during
exposure.
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Table 6. Calculated tissue/blood partition coefficients derived from (23)
Tissue 1,2,3-TMB 1,2,4-TMB 1,3,5-TMB
Brain 4.8 5.0 6.5
Kidney 3.1 3.2 4.0
Liver 5.5 5.8 7.5
Lung 1.6 1.6 1.8
Muscle 4.2 4.4 5.7
Small differences in the kinetics of the TMB isomers were found. The most easily
metabolised TMB seems to be the symmetrical 1,3,5-TMB which is logical
assuming no special demands on the enzyme-substrate interaction. Average blood
levels of 1,2,3-TMB were generally slightly higher and peaked at a level
significantly higher than the other TMBs (Figure 7). Further, the respiratory
uptake was lower for the 1,2,3-isomer. A slightly slower metabolic elimination of
1,2,3-TMB explains these findings. Assuming metabolism in the liver only,
hepatic extraction ratio at the 25 ppm-level averaged 0.28 ± 0.08 for 1,2,3-TMB
indicating that metabolism is to a great extent limited by the enzymatic capacity.
Corresponding values were 0.39 ± 0.07 for 1,2,4-TMB and 0.51 ± 0.08 for 1,3,5-
TMB indicating that both the enzymatic capacity and hepatic blood flow limit the
metabolism.
Table 7. Kinetic results after inhalation exposure to 25 ppm of TMB isomers in 9
(1,3,5-TMB only) or 10 male volunteers for 2 h at a work load of 50 W.
Exposure: 1,2,3-TMB 1,2,4-TMB 1,3,5-TMB
Respiratory uptake (%) 56 ± 4 64 ± 3 62 ± 3
Respiratory uptake (mmoles) 1.4 ± 0.1 1.6 ± 0.1 1.6 ± 0.1
Respiratory excretion (%)a 37 ± 9 20 ± 3 25 ± 6
Urinary excretion (ä)b 0.023 ± 0.008 0.010 ± 0.004 0.016 ± 0.015
CLtotal (lá kg-1 á h-1) 0.63 ± 0.13 0.68 ± 0.13 0.97 ± 0.16
CLexhalatory (lá kg-1 á h-1) 0.23 ± 0.07 0.14 ± 0.04 0.24 ± 0.10
CLmetabolic (l á kg-1 á h-1) 0.39 ± 0.11 0.54 ± 0.10 0.72 ± 0.11
Half time, 1st phase (min) 1.5 ± 0.9 1.3 ± 0.8 1.7 ± 0.8
2nd phase (min) 24 ± 9 21 ± 5 27 ± 5
3rd phase (h) 4.7 ± 1.6 3.6 ± 1.1 4.9 ± 1.4
4th phase (h) 78 ± 22c 87 ± 27 120 ± 41c
Volume of distribution (l/kg) 30 ± 6 38 ± 11 39 ± 8
Mean residence time (h) 57 ± 22 69 ± 32 42 ± 11
aduring and post exposure (0-¥ h), % of the respiratory uptake
bpost-exposure (0-4 h), ä of the respiratory uptake
cn=8
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Figure 7. Concentration of TMBs in capillary blood during and after exposure to 25 ppm.
Mean values of 9 (1,3,5-TMB) or 10 male volunteers are given.
Individual blood concentrations at steady state (Css) were calculated as:
Css = R0 / CL
where R0 = respiratory uptake rate and CL = total blood clearance.
The Css was significantly lower for 1,3,5-TMB (11 ± 2 mM) than for 1,2,3-TMB
(16 ± 2 mM) and for 1,2,4-TMB (18 ± 5 mM).
The interindividual variation in TMB in blood was generally below 20% during
all exposures. However, for the last two blood samples taken in the evening and in
the following morning, respectively, the coefficient of variation was elevated (23-
51%). After the 2 ppm exposure the interindividual variability increased already
at approximately 2 h post exposure.
Experimental and simulated blood concentration versus time curves generally
agreed well. Some deviations between predicted and experimental concentrations
may be explained by insufficient arterialisation of the blood.
A tendency, although not significant, towards non-linear kinetics was found in
the four-compartment analysis of exposure to 2 and 25 ppm 1,2,4-TMB (Paper
II). Small differences in respiratory and urinary excretion, mean residence time,
clearance and volume of distribution imply a deviation from linearity.
A significant difference in the 1,2,4-TMB kinetics at 2 and 25 ppm was indeed
found in the subsequent two-compartment analysis (Paper V). Thus, total
clearance was significantly higher at exposure to 2 ppm than at exposure to 25
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ppm 1,2,4-TMB. Exhalatory clearance did not, and should not, differ between
exposure conditions. Consequently, the difference in the kinetics between
exposure conditions was due to different metabolic clearance values.
Furthermore, the kinetics of 1,2,4-TMB after exposure to 2 ppm 1,2,4-TMB
alone and 2 ppm 1,2,4-TMB in white spirit differed in the same way. Blood levels
of 1,2,4-TMB as well as urinary excretion rates of 3,4-DMHA were significantly
higher after exposure to white spirit as compared with exposure to 1,2,4-TMB
alone (Figure 8).
All six possible DMHAs formed from the TMBs were detected in the urine of
the exposed men. The studied metabolic pathway was most important for the
elimination of 1,2,4-TMB. The 24-h excretion of DMHAs corresponded to
approximately 22% of the inhaled amount of 1,2,4-TMB. About 11% of the
absorbed amount of 1,2,3-TMB was excreted in the urine as DMHAs whereas
only 3% of 1,3,5-TMB was excreted as 3,5-DMHA. Unconjugated DMBAs
accounted for in round numbers 3% of the dose of all TMBs.
The half-times of DMHA excretion rate agreed well between exposure to
TMBs only and white spirit (Table 8). Half-times ranged from 4-8 h for all
DMHAs except maybe 3,5-DMHA for which some uncertainty about the half-
time remains. Half-times for creatinine-corrected concentrations did not differ
6543210
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Figure 8. Concentration of 1,2,4-TMB in capillary blood during and after exposure to 2
ppm 1,2,4-TMB, alone or in white spirit and to 25 ppm 1,2,4-TMB only (2 h, 50 W).
Mean values and 95% confidence intervals of 9 male volunteers are given.
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Table 9. Predicted biomarker levels for 10 subjects exposed to 25 ppm
1,2,4-TMB at 50 W 8 h daily for five consecutive days.
1,2,4-TMB in 3,4-DMHA 1,2,4-TMB in
venous blood in urine exhaled air
End of shift
Monday 6.6 (5.6-8.4) 2.1 (1.5-3.0) 2.8 (2.0-4.0)
Tuesday 7.0 (6.0-9.0) 2.3 (1.5-3.3) 2.9 (2.1-4.3)
Wednesday 7.4 (6.3-9.6) 2.4 (1.6-3.6) 3.0 (2.2-4.5)
Thursday 7.7 (6.5-10.0) 2.5 (1.7-3.8) 3.1 (2.3-4.7)
Friday 7.9 6.7-10.3) 2.6 (1.7-4.0) 3.2 (2.3-4.8)
Next morning
Tuesday 0.45 (0.36-0.58) 0.09 0.06-0.11) 0.06 (0.03-0.09)
Wednesday 0.73 (0.58-0.96) 0.15 (0.10-0.19 0.10 (0.06-0.16)
Thursday 0.96 (0.76-1.3) 0.20 (0.13-0.27) 0.13 (0.08-0.21)
Friday 1.1 (0.89-1.5) 0.24 (0.16-0.35) 0.16 (0.09-0.25)
Saturday 1.3 (0.99-1.8) 0.28 (0.18-0.41) 0.18 (0.11-0.29)
Monday 0.77 (0.59-1.01) 0.17 (0.11-0.23) 0.12 (0.07-0.18)
4.4 Acute symptoms
Ratings of smell during exposure to white spirit and 25 ppm TMB were high,
peaking at the first measurement in the chamber at an average of 35-37 mm for
the individual TMBs and at 56 for white spirit. Before leaving the chamber the
subjectsÕ average rating of smell had decreased to 20-26. Further, ratings of smell
differed significantly between the 2 and 25 ppm levels of 1,2,4-TMB. These
results indicate that the rating scale has an ability to pick up feelings of discomfort
in a quantitative manner.
No acute symptoms were reported at the studied conditions. Apart from the
ratings of smell, all average ratings were below the expression Òhardly any effect
at allÓ.
Table 10. Results from Monte Carlo simulations of random fluctuating 8-h exposures to
25 ppm 1,2,4-TMB at 50 W. Variability (coefficient of variation) in biomarker levels at
end of shift and next morning. Scenario 1 corresponds to continuous emission at a high
rate of air exchange. Scenario 2 is an intermittent emission at a low rate of air exchange.
End of shift Next morning
prior to shift
Scenario 1
1,2,4-TMB in venous blood (mM) 1.9 0.8
1,2,4-TMB exhalation rate (mmol/min) 13 0.5
3,4-DMHA excretion rate (mmol/min) 3.0 1.1
Scenario 2
1,2,4-TMB in venous blood (mM) 21 9.7
1,2,4-TMB exhalation rate (mmol/min) 64 7.5
3,4-DMHA excretion rate (mmol/min) 36 17
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5. Discussion
5.1 Toxicokinetic data analysis
The traditional toxicokinetic compartmental data analysis has developed rapidly
during the last years. However, as computer software is becoming more
sophisticated it may need to be stressed that the results depend on the quality of
the data as well as factors associated with the data analysis itself. At least some
kinetic parameter estimates will depend on the number of compartments in the
model used. Parameter estimates may also depend on the mathematical algorithm
used to fit the model to the data (69). In the present study, comparisons were
made for data analysed by identical software and procedures for fitting model to
data. However, when comparing results from different studies this should be kept
in mind. For a comprehensive survey of practical pharmacokinetic/-dynamic data
analysis the interested reader is referred to, e.g. Gabrielsson et al. (27).
A novel feature of the compartmental analysis in this study was the calculation
of the absorbed dose or amount as the sum of measured net uptake and the
amount cleared by exhalation during exposure. The traditional approach has been
to set dose equal to measured net uptake. As blood levels, and accordingly
exhalation rate, increase during exposure, measured net uptake decreases. Thus,
by this approach dose related parameters (such as clearance) will depend on the
exposure duration. On the other hand, by including clearance by exhalation during
exposure it is possible to distinguish between metabolic and exhalatory clearance
and the total clearance will be independent of the length of exposure. Lastly, but
very important, a more accurate estimation of internal dose is attained.
When analysing data from the single TMB-exposures a four-compartment
model was used. After white spirit exposures it was obvious that the shorter
follow-up time made the use of that model impossible. To be able to compare the
results from all different exposures to 1,2,4-TMB, all data concerning 1,2,4-TMB
exposure were re-analysed by a two-compartment model.
The classical databased analysis yields kinetic data for the exposure conditions
investigated. Expansions beyond the experimental domain, however, are not
possible. On the other hand, physiologically based toxicokinetic (PBTK) models
are biologically more realistic and to a great extent based on chemical
independent data such as tissue volumes and blood flow data. PBTK-modelling
has widened our understanding of the movement of chemicals in the body and of
the impact from different factors on tissue concentrations. By physiologically
based toxicokinetic modelling we can make predictions about tissue doses and the
influence from different exposure scenarios, working conditions and individual
characteristics. The increased understanding of the kinetics and its predisposing
factors via PBTK-modelling along with the development of sensitive analytical
methods has paved the way for biological monitoring and the strategies used for
it.
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5.2 Inhalation toxicokinetics of the TMBs
5.2.1 Uptake
The toxicological profile of a substance may vary with the route of
administration. For volatiles occurring in the occupational setting absorption via
the respiratory system or the skin is often of greater interest than uptake from the
gut wall. Both the lung and the skin exhibit a large surface area exposed to
xenobiotics. In the present study, chamber exposure to vapours was performed on
subjects wearing a T-shirt and shorts. Theoretically then respiratory and dermal
uptake may take place. However, dermal uptake of vapours of highly lipophilic
substances like the TMBs is expected to be very limited. Absorption of TMBs in
this study has therefore been considered to occur exclusively via the lung.
Pulmonary absorption is governed by alveolar ventilation, the blood flow through
the lung (cardiac output), the blood/air partition coefficient and elimination.
Experimentally obtained blood /air partition coefficients reflect both solubility
and binding. Saturable binding may lead to a deviation from the commonly
accepted idea that partition coefficients are constant irrespective of concentration
(73). Therefore, the determination of liquid/air partition coefficients in this study
was conducted at a wide concentration range covering what is expected to prevail
occupationally. No indications of a decreasing blood/air ratio with increasing
concentration were found.
For relatively lipophilic substances such as the alkylbenzenes, blood/air and
olive oil/air partition coefficients vary approximately according to vapour
pressure or boiling point. Thus, from the relatively high boiling points of the
TMBs, high blood/air partition coefficients could be expected. This was indeed
found and the partitioning to blood was even more pronounced for 1,2,4- and
1,2,3-TMBs than for styrene, an aromatic solvent often referred to as highly blood
ÒsolubleÓ.
The blood/air partition coefficient of 1,3,5-TMB was somewhat lower than
corresponding values for the other TMBs. The reason for the lower affinity of
1,3,5-TMB for blood is not clear. Interactions between single substances and
blood are complex. Hydrophobic solvents seem to be carried in blood mainly by
haemoglobin. It may be that the hydrophobic sites of haemoglobin are somewhat
rigid and different molecules may not fit equally well in these pockets (54). The
determination of the blood/air partition coefficient (43 ± 2.2) of 1,3,5-TMB in the
present study, however, agrees excellently with the value of 44 previously
reported (39). Also, the reported coefficient for 1,2,4-TMB of 54 (86) is close to
the result obtained in this study (59). The high blood/air partition coefficients of
the TMBs mean that essentially all TMB entering the alveoli will be absorbed by
the blood, i.e. absorption is limited by alveolar ventilation.
5.2.2 Distribution
Distribution is the transfer of the chemical to and from the site of measurement,
which in the present study is whole blood. The process is governed by the
partitioning behaviour of the substance.
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The olive/oil partition coefficients found in this study were very high, ranging
from 9 900 to 10 900 indicating extensive distribution to adipose tissue.
Accordingly, water/air partition coefficients were low. However, our result on the
water/air partitioning for 1,3,5-TMB (1.2) deviates from the earlier reported
urine/air partition coefficient of 18.5 (39). The reason for this discrepancy is not
understood. Rat tissue/blood partition coefficients in vivo can be calculated from
measured concentrations in different organs after exposure to TMB. The rat
fat/blood partition coefficient of 1,2,4-TMB in vivo has been determined to be 63
(92). This value is about half that indicated in the present study. Other data from
12-h inhalation experiments on rats suggests an in vivo fat/blood partition
coefficient of about 90 with large variations between groups of animals (18). In
the same study the brain/blood partition coefficient was on average 1.7, the
liver/blood as well as the kidney/blood partition coefficients were approximately
2. For this kind of data, high affinity tissue/blood concentration ratios tend to be
underestimated when measurements of mixed venous blood is performed whereas
the opposite holds for a tissue with a low true tissue/blood partition coefficient
(30). However, true tissue/blood partitioning coefficients for rats and humans may
differ. This is at least partly explained by the fact that many lipophilic compounds
have a greater affinity for rat blood than for human blood. For many low-
molecular weight volatiles, blood/air partition coefficients of rats have been found
to be 1.5-2.0 times that of humans. For o- and m-xylene a ratio of 1.3-1.4 is
reported (29).
In a classical compartmental analysis a measure of the extent of distribution is
the volume of distribution. Such apparent volume may be visualised as a
proportionality factor between total amount in the body and blood concentrations.
As this volume was found to be 30-40 l/kg for the TMBs, tissue/blood coefficients
must be high. However, no human data on tissue/blood partitioning was available
but from the liquid/air partition coefficients, tissue/blood coefficients can be
predicted which at equilibrium, govern the distribution in the body.
Kinetically, the process of distribution may be limited by perfusion or diffusion
across membranes. A small, lipophilic, uncharged molecule such as TMB is
assumed to diffuse rapidly across membranes and blood flow may be considered
to be rate limiting. Thus, the physiological model used in the present study, was
perfusion-limited.
5.2.3 Elimination
Elimination is the irreversible loss of the compound from the site of measurement
and comprises the processes of biotransformation (metabolism) and excretion.
Generally, biotransformation leads to more hydrophilic substances that can be
excreted more easily. For substances lacking functional groups, such as TMBs, an
initial oxidation step catalysed by the cytochrome P-450 system is required before
conjugation to a more water soluble product can occur. It is not known which
isoform of the P-450 system is involved in the oxidation of TMBs. However, the
ethanol-inducible CYP2E1 has been found to oxidise many relatively small
molecules like organic solvents, among them toluene and xylene (59, 67).
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Metabolic clearance of the TMBs was moderate and presumably limited by
both perfusion and the enzymatic capacity. No steady state was achieved during
the course of the 2-h exposures to 25 ppm. This is explained by the high blood/air
partition coefficient and the moderate metabolic rate.
A moderate metabolic clearance in combination with the large blood flow
through the lungs explains the relative importance of exhalation as a route of
elimination for the TMBs (20-37% of respiratory uptake) despite their high
blood/air partition coefficients. For the 1,2,3-isomer having the highest blood/air
partition coefficient of the TMBs, exhalation is still a more important route of
elimination due to a lower rate of biotransformation. For all TMBs, however,
experimental measurements of the exhalation rate may be somewhat
overestimated due to hyperventilation during sampling. The renal elimination of
the unchanged lipophilic TMBs was, as expected, negligible.
Total recovery in this work, taking all elimination routes studied into account,
was approximately 30-50% for the TMBs. Thus, a substantial portion of the
absorbed amount has not been accounted for. Considering the diverse spectrum of
metabolites possibly formed from the TMBs, this may not be surprising.
However, the low recovery of 3,5-DMHA (formed from 1,3,5-TMB) was
unexpected considering the results from earlier studies on animals (53, 64) and
also the human study by Kostrewski and co-workers (49). The difference between
our study and the latter may be explained by the fact that we analysed
unhydrolysed specimens whereas Kostrewski used hydrolysed urine thereby
analysing all possible conjugates of DMBA or even DMHA. The low excretion
rate of 3,5-DMHA found in the present study may be explained by a limited water
solubility. Indeed, 3,5-DMHA is the least polar of the DMHAs. Furthermore, it is
the least acidic (measured as pKa) of the DMHAs and hence, the degree of
ionisation in urine is the lowest. Sterical factors are known to influence
conjugation with glycine which may explain the lesser importance of this
metabolic pathway for 1,2,3-TMB as compared with 1,2,4-TMB.
Also, some sterical influence on the oxidation or glycine conjugation reactions
was seen in the relative excreted amounts of different DMHAs from the
respective TMBs which is particularly well illustrated by 1,2,4-TMB. The
dominating DMHA formed from 1,2,4-TMB was 3,4-DMHA, followed by 2,4-
DMHA. Excreted amounts of the most sterically hindered 2,5-DMHA were the
lowest. Thus, it seems as oxidation/glycine conjugation of positions lacking a
neighbouring methyl group is favoured.
Linear kinetics assumes first order transition rates between compartments, i.e.
the rate of change of the chemical is proportional to the amount present. Linear
kinetics implies also a clearance that is constant and independent of blood
concentration. Deviations from linearity may be due to saturable metabolism,
cofactor depletion, enzyme induction or inhibition. Inhibition of the metabolism
may be due to an effect on Vmax (the maximum rate of the enzyme-substrate
reaction) or Km (the substrate concentration giving a reaction rate of half Vmax) or
both. Interactions between xenobiotics do occur and have been shown for several
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pairs of substances, see e.g. (10, 84, 85). Generally, however, interactions have
been reported only at higher exposure levels than those used in the present study.
Synthetic mixtures of n-nonane, trimethylcyclohexane and 1,2,4-TMB vapour
given to rats at levels from 75 to 450 ppm of each substance indicated no
interactions between these substances within the experimental domain (18).
In the present study, however, in the initial four compartmental analysis, a
tendency (not significant) towards non-linear kinetics of 1,2,4-TMB was found
(Paper I). In the subsequent two compartment analysis, however, such a
difference appeared (Paper V). One possible explanation to the superior power of
the two compartmental analysis as compared with the four compartmental
analysis is the fact that the experimental error of the final data points from the 2
ppm exposure to 1,2,4-TMB was too large thereby deteriorating the possibility of
detecting any existing difference. By shortening the time of observation included
in the analysis, and comprising data points with a higher precision, the difference
emerged in the two compartment analysis. Despite indications of non-linear
kinetics of 1,2,4-TMB, formation of 3,4-DMHA, seemed relatively unaffected by
exposure condition. The urinary excretion rate of 3,4-DMHA was approximately
proportional to the area under time blood concentration time curve. Thus, other
metabolic pathways must be inhibited and the importance of the studied metabolic
pathway is thereby enhanced. As 1,2,4-TMB blood levels were elevated the first
step in the biotransformation must be inhibited. Indeed, initial oxidation by the P-
450 system is generally considered to be the rate limiting step (77). Some sterical
influence, although not pronounced, on the initial oxidation of 1,2,4-TMB in the
rat seems to occur (36). It may be that the somewhat more rapid oxidation of the
carbon in position 4 can proceed at an unaffected rate while the sterically less
favoured oxidations of carbon 1 and 2 are inhibited. Comparing the 3rd half-times
of the parent TMBs with that of the DMHAs, indicate that the formation (rather
than the excretion) of at least 3,4-DMHA (3.8 h) and 2,3-DMHA (4.8 h) is rate
limiting. The metabolites will then decline with the same half-time as the TMBs
(3.8 and 4.7 h, respectively). Regarding 3,5-DMHA, its half-time was not
unequivocally determined in this study. In practice, measurements of other
metabolites such as dimethylbenzyl alcohols and dimethylbenzoic acids would be
necessary to support the speculation of two metabolic pathways of different
kinetic orders.
The results from white spirit were unanticipated and must be interpreted with
caution. The experimental difficulties regarding the performance of exposures and
chemical analysis of complex mixtures are more pronounced than those
encountered for single substances.
For instance, the chamber air levels during exposures were monitored with
infrared spectrophotometry. This method was chosen to allow for real-time
monitoring and control of the chamber air. By this method, absorption in the
carbon-hydrogen stretching region was measured. Thus, in the white spirit
exposures, the level of several components instead of 1,2,4-TMB alone was
monitored. However, the fraction of 1,2,4-TMB was established separately by gas
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chromatography and the chamber air level of 1,2,4-TMB was calculated based on
that portion. Furthermore, complete vaporisation was assured when generating
standards and chamber vapours. Also, the slight difference between the single
exposures to 1,2,4-TMB supports the results from the white spirit exposures.
However, the results need to be verified.
5.3 Physiologically based modelling of 1,2,4-TMB inhalation kinetics
The main advantage of PBTK modelling compared with traditional data based
compartmental analysis is its predictive power. This is due to the fact that PBTK-
models to a large extent depend on chemical independent information but the final
model structure will also depend on chemical specific characteristics as well as
the aim of modelling. Like all models, PBTK models are simplifications of reality
which will help us understand important relationships and the effect of several
factors on tissue concentrations and hence, risk. However, one dimension of
diversity will be lost. For example, in the modelling process an initial
parameterisation is made based on group averages. From a study on inter-
individual variability in blood/air partition coefficients it was concluded that
although significant between-subject variation existed, most subjects could be
well represented by group mean values (14). The influence of food intake on
blood/air partition coefficients has been studied. Coefficients were larger in
samples collected after a meal than in samples collected after fasting (24).
Concerning tissue/blood partition coefficients, the variability may be more
pronounced. In a study by Pelekis and co-workers extreme values on lipid and
water content in different tissues were obtained from the literature (70). A
calculation of the corresponding tissue/blood partition coefficients for 1,2,4-TMB
indicated wide ranges for liver as well as muscle and adipose tissue/air
partitioning. Thus, although many physiological relationships used in PBTK-
modelling are well established, the uncertainty regarding some parameters may be
considerable.
Factors known to influence the kinetics of volatiles in humans are, e.g. body
size and build, sex, physical activity, exposure to other xenobiotics like ethanol
and mixed solvents (78). Such factors may be incorporated in the physiological
model. In this study the subjects (only males) were asked to refrain from alcoholic
beverages and medication prior to exposure. In the TMB-model, organ volumes
and blood flows were scaled according to lean body volume, and blood flows also
to the physical work load. Post exposure work load was set to 25 W instead of
commonly used 0 W which improved model fit. The modelled transition between
different work loads results in instantaneous changes in affected blood flows. In
reality, the process is gradual. Simplifications of this kind in the model may lead
to minor deviations between predicted outcome and experimental results.
As a Órule of thumbÓ the number of compartments should be kept as low as
possible to adequately describe the experimental data. The necessity of an
additional compartment depends on whether it contributes significantly to the
kinetic behaviour or to the toxicity of the chemical. For volatiles like the TMBs, a
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lung compartment is required. In the present model, as for most PBTK-models for
inhalation exposure of volatiles, the conducting airways were regarded as inert,
i.e. it is assumed that no interaction takes place between the chemical and the
surface of the mucous layer in the airways. This is presumably reasonable for
chemicals like the TMBs having a low water solubility (43). A special feature of
the model was the division of hepatic metabolism in two routes, one of the first-
order and one of the Michaelis-Menten type. The division was based on the
results from the chamber exposures indicating an overall slight deviation from 1st
order kinetics at 25 ppm. Despite the overall non-linear kinetics, the experimental
data suggested approximately linear formation of 3,4-DMHA. Another feature of
the model was the division of the muscle and skin compartment to account for the
effect on blood flow from physical exercise (44). The high TMB affinity for
adipose tissue warrant inclusion of a fat compartment.
Metabolism was assumed to occur in the liver only although some
biotransformation may occur in other organs such as the lung. Attempts to include
pulmonary metabolism in PBTK-models are reported (72). The TMBs have been
found to decrease CYP2E1 in the lung (74) which might indicate that pulmonary
metabolism of the TMBs occurs. However, as no more quantitative or precise
knowledge about that matter was at hand no extra-hepatic metabolism was
incorporated in the model.
Data on the liver metabolic constants were needed in the model. However, no
such data on 1,2,4-TMB was found. Furthermore, initial simulations revealed that
the use of literature data on alveolar ventilation at rest failed to mimic the
chamber exposure data. Thus, the experimental chamber exposure data were used
to find estimates of Vmax, Km, intrinsic clearance corresponding to formation of
3,4-DMHA, alveolar ventilation as well as the elimination rate constant of 3,4-
DMHA. By adjusting these parameters the model could adequately describe the
experimental data for all ten subjects. However, the model underpredicted the last
two blood concentrations in the evening on the day of exposure and the following
morning for most individuals which might indicate the presence of deeper fat
depots. Indeed, subcutaneous fat is known to have a lower perfusion than
perirenal fat (7). An attempt to divide the fat compartment into two with different
blood flows according to Fiserova-Bergerova (22) did not, however, improve the
fit. Also, literature data on fat perfusion is uncertain. Thus, in the final model no
division of the fat compartment was made.
The great impact from alveolar ventilation on the results for blood and exhaled
air was expected as it is a decisive factor for the uptake and exhalation. The
estimation of alveolar ventilation at rest (0 W) obtained from the experimental
exposures, approximately 9 l/min exceeds data in the literature, e.g. Malmberg et
al. (61) reports 6.6 ± 1.8 (mean ± sd), but our value is still within the normal
variation. Alveolar ventilation depends on the lean body volume. Several of the
participants in the chamber exposures were physically well trained. They may,
therefore, have less adipose tissue and accordingly a larger lean body volume than
an average man of the same body size. Thus, alveolar ventilation will be slightly
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increased. Another explanation is that the 1,2,4-TMB exhalation rate is
overestimated in the experimental measurements due to hyperventilation.
The effect on blood levels of the physical work load was pronounced. This is
expected for substances having a high blood/air partition coefficient (93). During
exercise, rate limiting pulmonary ventilation and cardiac output increases which
favours the absorption.
The Michaelis-Menten kinetics results in disproportionality between all
biomarker levels and 1,2,4-TMB in air. Saturation kinetics will be more
pronounced at higher TMB air levels. Thus, the approximate first order formation
of 3,4-DMHA means that the importance of 3,4-DMHA formation in the
elimination of 1,2,4-TMB will gradually increase with increasing air levels since
the other metabolic routes gradually become more saturated.
5.4 Biological monitoring of TMB exposure
Biological markers may be defined as molecular, biochemical or cellular changes
that are measurable in biological media (35). They represent some event occurring
between exposure and disease. Sometimes biomarkers are classified as belonging
to either of the following categories: exposure, effect and susceptibility, although
the range of markers in fact represents a continuum. In the following the
discussion will focus on monitoring of exposure. Our ultimate concern is the
target tissue dose (or even the so called biologically effective dose) but surrogate
tissue levels such as blood or urine concentrations are often used. A proper
selection and use of biomarkers of exposure must be based on the kinetics of the
toxicant and its biomarker. Kinetics governs whether peaks or average levels, and
what exposure period, will be reflected by the measurement. Further, the timing
of sampling has to be based on the kinetic behaviour. Generally, for highly
metabolised substances the level of major metabolites correlates better with
exposure than the parent molecule (16). Endogenous or background levels of the
markers must be considered as well as the interindividual variability. Differences
between or within subjects that reflect toxicological differences in internal dose or
metabolic capacity should be reflected by the biomarker. Otherwise such
differences add to the random background noise. Further, the precision of the
analytical assay must be known. The coefficient of variation for a biomarker at
different time points will partly reflect a ÓtrueÓ biological variability but is
naturally linked to the method used as the analytical error is part of the measured
variation. The decision to use a certain chemical as biomarker of exposure must
be based on all of these factors together with practical considerations.
In the case of the highly metabolised TMBs, metabolites may be appropriate as
biological exposure marker. Other potential biomarkers are TMB-exhalation rate
and TMB in venous blood.
Reported urban air levels of the TMBs are in the ppb-ppt-range (55, 81-83) and
should not affect the estimates of occupational exposures at the ppm-level. No
endogenous formation of DMHAs seems to exist.
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After the 25 ppm experimental exposures to TMBs, the variability between
subjects was investigated for DMHA excretion. Half-times of excretion rates,
creatinine-corrected and uncorrected concentrations were measured. Excretion
expressed as rate showed the least variability. Urine collection, however, may in
practice be difficult to achieve. Spot sampling might therefore be a reasonable
straightforward alternative. Correction for creatinine improved the precision
compared with using uncorrected concentrations. The latter is natural since no
correction for dilution is achieved. Creatinine-correction is based on the
assumption that the creatinine-excretion is stable over time and not influenced by
urine flow rate. This assumption however, has been questioned (2). Adjustment
by the specific gravity of the urine specimen is an alternative that does adjust for
varying excretion rates of water, but not of any solutes. These two ways of
adjusting concentrations are not necessarily interchangeable.
The variability between subjects in DMHA excretion rate was less pronounced
for a few hours after exposure. This may indicate that metabolic differences do
not have an effect until after some time has past or reflect a somewhat lower
analytical precision at lower concentrations. After exposure to single TMBs a
summation of the excretion rate of all DMHAs or the excretion rate of 3,4-DMHA
had approximately the same variability. After white spirit exposures a summation
of DMHAs or 3,4-DMHA had approximately the same variability.
Due to analytical difficulties after white spirit exposure only blood levels of
1,2,4-TMB could be analysed quantitatively. Thus, in the PBTK model it was
possible to evaluate 3,4-DMHA as a biological exposure marker but not any
markers originating from the other TMBs.
In the PBTK-model, the effect on different biomarkers of a) long term
exposure, b) 1,2,4-TMB air levels, and c) work load was simulated.
Simulations of a working week suggested that the biomarker levels a the end of
shift remain fairly constant whereas the levels prior to shift increase gradually
during the week. It is reasonable to assume that the constant end of shift levels
reflect recent exposure (same day) whereas sampling on Friday morning or the
following Monday morning will indicate the exposure during the entire working
week.
Work load had a pronounced influence on 1,2,4-TMB biomarker levels. Thus,
biological monitoring may be advantageous since internal dose during the
performance of certain work tasks may be incorrectly estimated by ambient air
monitoring.
The importance of the metabolic route yielding 3,4-DMHA increases with
increasing air levels. The effect is more pronounced at the end of shift than prior
to shift because blood levels at the end-of-shift are high.
As expected, the variability in biomarker levels caused by fluctuating exposures
was more pronounced end of shift than next morning. After intermittent emissions
with a minimal rate of air exchange the predicted variability in 3,4-DMHA
excretion was enhanced compared with the variability of other biomarker levels.
This is presumably due the increased importance of 3,4-DMHA formation in the
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elimination of 1,2,4-TMB with increasing air levels. The importance of 3,4-
DMHA formation in the overall elimination of 1,2,4-TMB will then vary with the
fluctuating exposure pattern.
The interindividual variation in arterial blood levels end of shift was 13-15%
during the consecutive days, approximately the same as found experimentally.
The simulated variation in blood levels is much less than the interindividual
variation between single model parameter estimates. This is explained by a co-
variation between some of the parameters. The subjects in the experimental
exposures were all healthy, physically fit, Caucasian males between 26 and 48
years of age. Thus, the variability in this group is presumably smaller than the
variability in the general population.
1,2,4-TMB in venous blood or 3,4-DMHA in urine seem suitable as biological
markers of TMB exposure. Venous blood levels are slightly less sensitive to air
fluctuations. Sampling, however, is invasive and therefore complicated to perform
in field studies. On the other hand, urine sampling is non-invasive and the clean-
up procedure of the specimen is often easier than that of blood specimens.
Analysis of exhaled air is easy but the sampling procedures critical. Further, end
of shift levels are highly influenced by the most recent exposure. In general,
sampling at the end of shift gives a measure of the exposure during that day
whereas sampling prior to shift towards the end of the week or on the following
Monday morning will reflect exposure during the whole week.
5.5 Acute symptoms
The anaesthetic or narcotic potency of several substances is reported to relate to
their olive oil/air or serum/air partition coefficient (65, 66). As pointed out by
Sato and co-workers (79) the anaesthetic effect of benzene and its methylated
derivatives is expected to increase with the number of methyl groups.
Accordingly, the TMBs would be more potent in this respect than toluene and
xylene.
In the present study ratings of smell during exposure to white spirit and 25 ppm
TMB were high, peaking at an average of about 55 and 35-37 mm. Further,
ratings of smell differed significantly between the 2 and 25 ppm levels of 1,2,4-
TMB. These results indicate that the rating scale has an ability to pick up feelings
of discomfort quantitatively. The scale itself was validated to noise. The present
questions have not been validated against objective measures.
By the questionnaire, no acute symptoms were reported during short-time
exposure at the present OELs of trimethylbenzenes and white spirit in Sweden.
However, the absence of symptoms does not exclude the possibility of acute
effects caused by TMBs. The study was designed for the kinetics and more
subjects would have been needed to properly study acute symptoms. Chamber
studies, are labour intensive and costly which makes it difficult to study large
groups. Also, a selection bias is difficult to avoid in exposure studies since
sensitive individuals probably do not volunteer. The small group and the selection
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bias in the recruitment of volunteers means that effects that would be seen in a
large, more representative sample of the whole population may not be detected.
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6. Conclusions
The toxicokinetics of the TMBs is characterised by:
A high respiratory uptake and a pronounced affinity for adipose tissue and,
thus, a potential for accumulation and a slow terminal elimination
governed by wash-out from adipose tissue.
Moderate metabolic clearance-values indicating both capacity and flow
limited metabolism.
Indications of deviations from first order kinetics were found at an
exposure level equal to the present Swedish occupational exposure limit
(25 ppm) of 1,2,4-TMB.
Indications of interaction effects from other components in white spirit on
the kinetics of 1,2,4-TMB.
A non-linear relationship for 1,2,4-TMB between blood and exposure
levels suggesting partial metabolic saturation.
The physiologically based model developed for 1,2,4-TMB implied that:
1,2,4-TMB in venous blood and 3,4-DMHA in urine are suitable as
biological markers of 1,2,4-TMB exposure.
The importance of 3,4-DMHA formation in the metabolism of 1,2,4-TMB
will increase with increasing TMB air levels. Thus, 3,4-DMHA in urine is
non-linearly related to 1,2,4-TMB exposure.
Work load has a profound influence on internal exposure to 1,2,4-TMB
and on the excretion of 3,4-DMHA.
Biological sampling end of shift gives a measure of the exposure during
the same day whereas sampling prior to shift towards the end of the week
reflect exposure during the entire week.
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7. Summary
Jrnberg, J. Toxicokinetics of inhaled trimethylbenzenes in man. Arbete och
Hlsa 1998:1
In the toxicological risk assessment, data on the uptake and disposition
(toxicokinetics) of the chemical is important. The three isomeric
trimethylbenzenes (TMBs) are widely used as components in solvent mixtures
and motor fuels. The aim of the present investigation was to study the human
toxicokinetics of inhaled TMB vapours and in particular of 1,2,4-TMB.
Liquid/air partition coefficients of the TMBs were determined in vitro by the
vial equilibration method. The results indicate a pronounced affinity for blood and
adipose tissue whereas partitioning to water was low. Inhalation chamber
exposures of male healthy volunteers were performed for 2 h during light physical
exercise. Exposure level for each TMB-isomer was 25 ppm. In addition, an
exposure to 2 ppm of 1,2,4-TMB was performed. Furthermore, the same men
were exposed to 2 ppm of 1,2,4-TMB in white spirit. A method for determination
of dimethylhippuric acids (DMHAs), specific metabolites of TMBs, was
developed. The excretion of DMHAs in urine after TMB exposure was measured.
The relative respiratory uptake was high (56-64%) and exhalation of
unmetabolised TMBs amounted to 20-37% of the absorbed amount. The results
from the different exposure conditions indicate a tendency towards a deviation
from first order kinetics for 1,2,4-TMB at the present Swedish occupational
exposure limit (25 ppm). This suggests partial metabolic saturation. In addition,
1,2,4-TMB kinetics was affected by other components in white spirit.
The recovery of DMHAs within 24 h varied between the TMBs isomers in the
range 3-22% of the absorbed amount. Half-times of the DMHAs were in the range
4-8 h. The data suggests that the importance of the metabolic route yielding 3,4-
DMHA from 1,2,4-TMB increases with increasing air levels and after exposure to
white spirit.
A physiologically based toxicokinetic model was developed for 1,2,4-TMB
using blood and exhaled air levels of 1,2,4-TMB as well as urinary excretion rates
of 3,4-DMHA from the two exposures to 1,2,4-TMB. The model was used to
expand from a 2 h exposure to exposure for 8 h at different work loads and
different air levels as well as exposure during a working week. Simulations
indicated that work load has a pronounced influence on 1,2,4-TMB levels in
blood and exhaled air as well as the excretion of 3,4-DMHA. Thus, for certain
work tasks internal exposure may be incorrectly estimated by air monitoring.
1,2,4-TMB in venous blood or exhaled air and the urinary excretion of 3,4-
DMHA can be used as biological indicators of 1,2,4-TMB exposure. Sampling at
the end of the working shift gives an indication of the same dayÕs exposure
whereas sampling prior to shift towards the end of the week or after the weekend
reflects the exposure during the entire week.
Key words: trimethylbenzene, dimethylhippuric acid, white spirit,
toxicokinetics, biological monitoring, human
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8. Sammanfattning (Summary in
Swedish)
Jrnberg, J. Toxicokinetics of inhaled trimethylbenzenes in man. Arbete och
Hlsa 1998:1
Vid toxikologisk riskbedmning av kemiska mnen r kunskaper om mnenas
upptag och omsttning (toxikokinetik) viktiga. De tre isomererna av
trimetylbensener (TMB) frekommer allmnt i lsningsmedelsblandningar och
motorbrnslen. Syftet med studien var att studera upptag och omsttning av
trimetylbensener hos mnniska.
Frdelningskvoter (vtska/luft) fr trimetylbensener bestmdes in vitro i blod,
olivolja och vatten. Resultaten tyder p en uttalad affinitet fr blod och fettvv.
Friska, frivilliga mn exponerades i en kammare fr ngor av trimetylbensen i 2 h
under ltt fysiskt arbete. Exponeringsniverna var 25 ppm av var och en av isome-
rerna och dessutom 2 ppm 1,2,4-TMB. Samma frskspersoner exponerades dess-
utom fr 2 ppm 1,2,4-TMB i lacknafta. En metod utvecklades fr bestmning av
dimetylhippursyror (DMHA) som r specifika metaboliter av trimetylbensener.
Utsndringen av DMHA i urin mttes efter exponeringarna fr trimetylbensener.
Det relativa upptaget av trimetylbensener via andningsvgarna var hgt (56-
64%) och utandning av ometaboliserat lsningsmedel uppgick till 20-37% av
upptagen mngd. Resultaten frn de olika exponeringsbetingelserna indikerade en
avvikelse frn frsta ordningens kinetik fr 1,2,4-TMB redan vid det nuvarande
svenska nivgrnsvrdet p 25 ppm. Dessutom indikerade lacknaftaexponeringen
att kinetiken fr 1,2,4-TMB pverkas av vriga komponenter i blandningen.
Utbytet av DMHA inom ett dygn efter pbrjad exponering varierade fr de tre
isomererna mellan 3 och 22% av upptagen mngd. Halveringstiderna fr DMHA
var 4-8 timmar. Resultaten indikerar att betydelsen av den metabolismvg som
ger 3,4-DMHA kar med kande lufthalter av 1,2,4-TMB.
En fysiologiskt baserad toxikokinetisk modell utvecklades fr 1,2,4-TMB med
hjlp av data frn de tv exponeringarna avseende 1,2,4-TMB i blod och
utandningsluft samt utsndringen av 3,4-DMHA. Modellen anvndes fr att
expandera frn en 2 timmars exponering till heldagsexponering vid olika fysisk
arbetsbelastning och exponeringsniver. Simuleringarna visade att
arbetsbelastningen har stor betydelse fr niverna av 1,2,4-TMB i blod och
utandningsluft. Exponeringen vid tungt fysiskt arbete kan drfr underskattas vid
mtning av halten 1,2,4-TMB i luft. 1,2,4-TMB i venst blod eller utandningsluft
och 3,4-DMHA i urin kan anvndas som biologiska markrer fr TMB-
exponering. Provtagning vid slutet av ett arbetspass speglar dagens exponering
medan provtagning p morgonen mot slutet av veckan ger ett mtt p hela
veckans exponering.
Nyckelord: trimetylbensen, dimetylhippursyra, lacknafta, toxikokinetik,
biologisk monitorering, mnniska
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